Tuesday, 4 April, 2023 - 11:59
US investor backs WA manufacturing
Five months after striking a deal to buy Pfizer’s WA manufacturing operation, Bridgewest Group has completed the purchase and outlined plans to add to its 400 local staff.
Ian Wisenberg has over 30 years of experience in international business, business development, corporate development, access to capital and finance, and in establishing strategic financial partnerships with local, national and international institutions.
Mr Wisenberg has been the executive chair of BioCina since March 2023, having been its chief executive for 2.5 years prior. He is also the operating partner and Australasia representative of Bridgewest Group, a US private investment firm which acquired BioCina (Pfizer's manufacturing facility in Adelaide) in late 2020.
![]() |
NEW ROLE: Non-Executive Director, Clever Culture Systems | 07 Oct 2024 |
![]() |
NEWS: Tagged in US investor backs WA manufacturing | 04 Apr 2023 |
![]() |
NEW ROLE: Operating Partner, Bridgewest Perth Pharma | 04 Apr 2023 |
Five months after striking a deal to buy Pfizer’s WA manufacturing operation, Bridgewest Group has completed the purchase and outlined plans to add to its 400 local staff.
Three businesses formed in Perth have been given a new lease of life after being acquired by global players.
Access to our data for Ian Wisenberg is only available to paid subscribers with Data & Insights access.
Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.
Ian Wisenberg is linked to 2 organisations which are included in 1 list - Public Companies - non WA.
To see the data you will need to Subscribe.